PET Scans of Abdominal Malignancy
- 1 February 1996
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 20 (2) , 245-247
- https://doi.org/10.1007/s002689900039
Abstract
Positron emission tomography (PET) with fluorine-18-2-d-deoxyglucose (FDG) currently is being integrated into clinical oncology because it provides unique functional information that can be applied to the management of cancer. In particular, it is useful for assessing tumor activity and growth, evaluating efficacy of therapy, and detecting tumor recurrence. Studies have demonstrated the value of whole-body PET-FDG imaging when staging and managing abdominal malignancy.Keywords
This publication has 0 references indexed in Scilit: